EVAX FY 2024 Earnings — Evaxion Biotech A/S Revenue & Financial Results | Market Cap Arena

EVAXEvaxion Biotech A/S

$20M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+4480.8% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$15M-440.6% margin

Net Income

-$11M-316.0% margin

EPS (Diluted)

$-9.80

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$357,000

Balance Sheet

Total Assets

$12M

Total Liabilities

$14M

Stockholders' Equity

-$2M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$73,000	+4480.8%
Gross Profit	$3M	$73,000	+4480.8%
Operating Income	-$15M	-$22M	+33.6%
Net Income	-$11M	-$22M	+52.2%